Rose A. Baska

Dual Angiotensin II and Endothelin A Receptor Antagonists:  Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics

Natesan Murugesan, Zhengxiang Gu, Leena Fadnis et al. · Journal of Medicinal Chemistry · 2004 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of <i>N</i>-Isoxazolyl Biphenylsulfonamides as Potent Dual Angiotensin II and Endothelin A Receptor Antagonists

Natesan Murugesan, John E. Tellew, Zhengxiang Gu et al. · Journal of Medicinal Chemistry · 2002 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension

Mark C. Kowala, Natesan Murugesan, John E. Tellew et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 52 citations

Medicine, Cardiology, Pharmacology +17

Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series

Bruce A. Ellsworth, Ying Wang, Yeheng Zhu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of 4′-[(Imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/Angiotensin II receptor antagonists

John E. Tellew, Rose A. Baska, Sophie Beyer et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11